Pharmamel is a biotechnology company that emerged from the University of Granada’s spin-off program.
It was born in 2014, but its history goes back for many years. Since the beginning of the 1990s, researchers Darío Acuña-Castroviejo and Germaine Escames have been carrying out crucial research work in the field of cell aging and melatonin, and the application of melatonin in different areas, including skin.
Pharmamel puts these researchers’ investigative experience at the service of society.
We aim to discover and develop new technologies, making our innovations available to everyone, and to achieve this, we adapt to the needs of society.
All of this can be achieved thanks to our highly-qualified team, because knowledge resides in people and they are our company’s engine.